Sellers Stephanie L, Trane Andy E, Bernatchez Pascal N
Department of Anesthesiology, Pharmacology and Therapeutics and The James Hogg Research Centre, University of British Columbia Vancouver, BC, Canada.
Front Physiol. 2012 Jul 18;3:280. doi: 10.3389/fphys.2012.00280. eCollection 2012.
Caveolae and caveolin are key players in a number of disease processes. Current research indicates that caveolins play a significant role in cardiovascular disease and dysfunction. The far-reaching roles of caveolins in disease and dysfunction make them particularly notable therapeutic targets. In particular, caveolin-1 (Cav-1) and caveolin-3 (Cav-3) have been identified as potential regulators of vascular dysfunction and heart disease and might even confer cardiac protection in certain settings. Such a central role in vascular health therefore makes manipulation of Cav-1/3 function or expression levels clear therapeutic targets in a variety of cardiovascular related disease states. Here, we highlight the role of Cav-1 and Cav-3 in cardiovascular health and explore the potential of Cav-1 and Cav-3 derived experimental therapeutics.
小窝和小窝蛋白是许多疾病进程中的关键参与者。当前研究表明,小窝蛋白在心血管疾病和功能障碍中发挥着重要作用。小窝蛋白在疾病和功能障碍中的广泛作用使其成为特别值得关注的治疗靶点。特别是,小窝蛋白-1(Cav-1)和小窝蛋白-3(Cav-3)已被确定为血管功能障碍和心脏病的潜在调节因子,甚至在某些情况下可能具有心脏保护作用。因此,在血管健康中如此核心的作用使得操纵Cav-1/3的功能或表达水平成为各种心血管相关疾病状态下明确的治疗靶点。在此,我们强调Cav-1和Cav-3在心血管健康中的作用,并探讨源自Cav-1和Cav-3的实验性治疗方法的潜力。